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observed from Ayurvedic literature and ethanobotanical 
studies that the plant Adiantum venustum Don is very useful 
in treating tumor, prevention of hair from falling, and as 
a diuretic, but no scientific investigation has been carried 
out.[2-4] Therefore, it was thought worthwhile to carry out 
preliminary phytochemical screening and screening of A. 
venustum Don for anticancer activity against Ehrlich Ascites 
Carcinoma in animal model.
MATERIALS AND METHODS
Plant source
The leaves and stem of A. venustum Don [Figure 1] were 
collected from Kolli Hills, Namakkal District, Tamilnadu, 
India, and were authenticated. Reference number of the 
authentication report is BSI/SC/5/23/05.06/Tech/603.
Extraction procedure
The leaves and stem of A. venustum were dried under shade, 
mixed together, and then made in to a coarse powder in 
INTRODUCTION
The chemotherapy of neoplastic disease has become 
increasingly important in recent years. The relatively 
high toxicity of most anticancer drugs has fostered the 
development of supplementary drugs that may alleviate 
this toxic effect or stimulate the regrowth of depleted 
normal cells. Plants have a long history of use in the 
treatment of cancer, and they have played a vital role as a 
source of effective anticancer agent. It is significant that 
over 60% of currently used anticancer agents are derived, 
in one way or another, from natural sources, including 
plants, marine organism, and microorganisms.[1] It was also 
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Cancer is a malignant disease that is characterized by rapid and uncontrolled formation of abnormal cells which 
may mass together to form a growth or tumor, or proliferate throughout the body. Next to heart disease, cancer 
is a major killer of mankind. This study aims at a preliminary phytochemical screening and anticancer evaluation 
of Adiantum venustum Don against Ehrlich Ascites Carcinoma in animal model. The findings indicate that 
ethanolic extract of A. venustum Don possesses significant anticancer activity and also reduces elevated level 
of lipid peroxidation due to the presence of terpenoids and flavonoids. Thus, ethanolic extract of A. venustum 
Don could have vast therapeutic application against cancer.
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a mechanical grinder. The powder was passed through 
sieve no. 40 and stored in an airtight container for further 
use. The dried powder material (150 g) was defatted with 
petroleum ether (60–80°) to remove waxy substances and 
chlorophyll. The marc, after defatted with petroleum ether, 
was dried and extracted with ethanol (99.9% v/v) in a 
Soxhlet extractor for 72 h. The solvent was then distilled 
off, and the resulting semisolid mass was dried in a vacuum 
evaporator to get a yield of 14% w/w.[5,6]
Phytochemical identification tests
Various chemical tests were performed for the identification 
of phytoconstituents in Pet. ether and ethanolic extract of 
the leaves and stem of A. venustum following the standard 
procedure.[7,8]
Anticancer activity
Toxicity evaluation (LD50): (Karber’s methods)[9–11]
Swiss albino mice weighing 20–25 g were used for the study. 
Animals were fed a standard pellet and water and maintain 
at 24–28 °C temperature, 60–70% relative humidity and 
12 h day and night cycle. Animals ascribed as fasted were 
deprived of food for 16 h, but had free access to water.
Fifty-four mice including both male and female weighing 
20–25 g were selected for the study. Overnight faster mouse 
were divided into nine groups including four for PEETR 
and four for EETR and one control group each consists 
of six mice. Different doses of extract (200, 500, 1000, 
and 2000 mg/kg) were administered to nine experimental 
groups and control group received vehicle.
The animals observed continuously for their general 
behavior, such as motor activity, tremors, convulsions, 
straub reaction, Pilo – eraction, loss of lighting reflex, 
sedation, muscle relaxation, hypnosis, analgesia, ptosis, 
lacrimation, diarrhea, skin color, and mortality intermittently 
for next 24 h.
Animals
Male Swiss albino mice, weighing between 18 and 25 g, were 
used for this study. They were maintained under standard 
environmental conditions and were fed with standard 
pellet diet of water ad libitum. The mice were acclimatized 
to laboratory condition for 10 days before commencement 
of experiment. All procedure described were reviewed and 
approved by the Institutional Animal Ethical Committee of 
Smt R. B. P. Mahila Pharmacy College (rbpmpc/09/1025).
Cancer cell line
EAC cells were obtained from Amala Cancer Research 
Center, Kerala, India. They were maintained by weekly 
intraperitoneal inoculation of 106 cells/mouse.
Preparation of  extract drug and mode of  administration
In the present anticancer study, ethanolic extract of 
Adiantum venustum (EEAV), in the dose of 150 and 250 
mg/kg, were prepared as suspension by dispersing the 
ethanolic extract in a mixture of propylene glycol and sterile 
physiological saline containing Tween 20 (1:3) to get the 
desired concentration.[12,13]
Tumor transplantation 
Ehrlich’s Ascites Carcinoma was maintained by serial 
transplantation from tumor-bearing Swiss Albino mice. 
Ascetic fluid was drawn out from tumor-bearing mice at 
the log phase (day 78 of tumor bearing) of the tumor cells. 
The tumor cell number was adjusted to 2 × 106 tumor cells/
mL. Sample showing more than 90% viability was used for 
transplantation. Each animal received 0.2 mL of tumor cell 
suspension containing 2 × 106 cells/mL intraperitoneally.[11]
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Drug treatment schedule
Male swiss albino mice were divided into five groups (n 
= 8).  All the groups were injected with EAC cells (0.2 
mL of 2 × 106 cells/mouse) intraperitoneally except the 
normal group. This was taken as day 0. From the first 
day normal saline (0.9% NaCl), 5 mL/kg of body weight 
was administered to group 1 and propylene glycol 5 mL/
kg was administered to group 2 (cancer control) for 14 
days intraperitoneally. Similarly ethanolic extract of A. 
venstrum don at various doses (150 and 250 mg/kg/mouse/
day) were administered to animals of groups 3 and 4, 
respectively. Standard drug vincrystine (0.8 mg/kg/day/
mice) was administered to the group 5. After administration 
of last dose followed by 18 h fasting, four mice form 
each group were sacrificed for the study of anticancer 
activity, hematological, and liver biochemical parameters. 
The remaining animals in each of the groups were kept to 
check the mean survival lime (MST) and percent increase 
in life span of the tumor-bearing hosts.[12–14] Various 
parameters such as body weight of animals, life span of 
animals, cytological studies of cell lines, hematological 
parameters, RBC, WBC, hemoglobin, differential count, 
and biochemical parameters were evaluated in this study. 
Anticancer effect of EEAV was assayed by observation of 
change with respect to body weight, ascitic tumor volume, 
packed cell volume, viable and nonviable tumor cell count, 
mean survived time (MST), and percentage increase in life 
span (% ILS).[12]
Tumor cell volume and packed cell volume 
The mice were dissected to collect ascitic fluid from 
peritoneal cavity and centrifuged to determine packed 
cell volume at 1000 rpm for 5 min.[12] The transplantable 
murrain tumor was carefully collected to measure the 
tumor volume.
Viable and nonviable cell count
Viable and nonviable cell counting of the ascetic cell was 
done by staining with tryphan blue (0.4% in normal saline), 
dye exclusion test, and count was determined in a Neubauer 
counting chamber. The cells that did not take up the dye 
were viable and those that took the stain were not viable.[14]
Mean survival time and percent increased in life span
The effect of EEAV on tumor growth was observed by 
MST and % ILS. MST of each group continuing four mice 
were monitored by recording the mortality daily for 6 weeks 
and % ILS was calculated by using following equation.[15,16]
MST = (Day of first death + Day of last death)/2.
% ILS = {
MST of treated group
MST of control group } 1 × 100.
Effect of  EEAV on hematological parameters
Blood was collected from each mice by intracardial 
puncture with blood anticoagulant (heparin), white blood 
cells (WBCs), red blood cells (RBCs), hemoglobin, and 
differential count were determined[17] in group comprise of 
i.  Tumor-bearing mice (control), 
ii.  tumor-bearing mice treated with EEAV (100 mg/kg/
mice/day), 
iii. tumor-bearing mice treated with EEAV (200 mg/kg/
mice/day), and
iv.  normal group.
Biochemical assay
After the collection of blood samples, the mice were killed, 
and their liver was excised. The isolated liver was rinsed in 
ice-cold normal saline followed by cold phosphate buffer 
having pH 7.4, blotted dry, and weighed. A 10% w/v 
homogenate of liver was prepared in ice-cold phosphate 
buffer (pH 7.4), and a portion were utilized for estimation 
of lipid. Other portion of the same, after precipitation of 
proteins with trichloro acetic acid (TCA), was used for the 
estimation of glutathione and the remaining homogenate 
was centrifuged at 1500 rpm at 4 °C for 15 min. The 
supernatant, thus obtained, was used for the estimation 
of superoxide dismutase, catalase, and protein content.[18]
Statistical analysis
The experimental result were expressed as mean ± SEM. 
Data were assessed by the Student t-test, P < 0.05 was 
considered as statistically significant.
RESULTS
Phytochemical screenings suggest that ethanolic extract 
of plant contain terpenoid, phytosterols, flavanoid, and 
saponin which are believed to be the main potential for 
anticancer activity [Table 1].[19,20]
Anticancer activity
Toxicity evaluation (LD50)
In acute toxicity study, the given extract of A. venustum 
Table 1: Result of phytoconstituent identification tests 
of ethanol extract of Adiantum venustum Don
Phytoconstituent Phytosterol Flavonoids Triterpenoids Saponin
Ethanol extract + + + +
+ represents present, – represents absent
Viral, et al. J Young Pharm. 2011;3(1): 48-54Journal of Young Pharmacists Vol 3 / No 1  51
Anticancer evaluation of A. venustum Don
Table 2: Effect of ethanol extract of Adiantum 
venustum on survival time on EAC-bearing mice
Experimental groups Mean survival time 
(MST), days
% Increase in life 
span
Normal control 
GRP 1 – –
EAC control
GRP 2
22 ± 0.25 –
150 mg/kg
GRP 3
24 ± 0.33 9.09
250 mg/kg
GRP 4
29 ± 0.49 31.81
STD
GRP 5
31 ± 0.55 40.90
Values are mean ± SEM. Number of mice in each group (n = 8), P < 0.001. 
Experimental group was compared with EAC control
Table 3: Effect of ethanol extract of A. venustum on tumor volume, packed cell volume, viable, and nonviable tumor 
cell count of EAC-bearing mice
Parameters Normal  
GRP 1
EAC Control  
GRP 2
150 mg/kg  
GRP 3




Body weight 26.11 ± 0.12 26.11 ± 0.12 24.34 ± 0.16 23.28 ± 0.13 23.9 ± 0.02
Tumor volume (mL) 0 5.82 ± 0.042 4.22 ± 0.051 3.42 ± 0.082 2.42 ± 0.13
Packed cell volume (mL) 0 2.12 ± 0.104 1.75 ± 0.043 1.05 ± 0.092 1.15 ± 0.03
Viable tumor cell count, % 107 cells /mL 0 11.25 ± 0.098 7.78 ± 0.18 4.85 ± 0.23 4.90 ± 0.015
Nonviable tumor cell count, ×107 cells/mL 0 0.5 ± 0.017 0.92 ± 0.023 1.47 ± 0.021 1.23 ± 0.81
Values are mean ± SEM. Number of mice in each group (n = 8), P < 0.01. Experimental groups was compared to EAC control weight of normal mice = 20 ± 0.15
Figure 2: Graphical representation of Mean survival time and % 
increase in life span of mice
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Figure 3: Graphical representation of effect of EEAV on tumor volume 
and packed cell volume of mice, viable cell count and non viable cell 
count
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did not show any mortality up to the dose of 2000 mg/
kg. It is safe dose that was determined by organization 
for economic cooperation and development (OECD) 
guidelines. The extract shows sedation, hypnosis, and mild 
muscle relaxant property. Administration of EEAV reduces 
the tumor volume, packed cell volume, and viable tumor 
cell count in a dose-dependant manner when compared 
to EAC control mice. In EAC control mice, the median 
survival time was 22 ± 0.25 days. Whereas, it was significant 
increased median survival time (24 ± 0.33, 29 ± 0.49) 
with different doses (150 and 250 mg/kg) of EEAV and 
standard drug, respectively. The mean survival time (MST) 
and the effect of EEAV (150 and 250 mg/kg) at different 
doses on tumor volume, viable, and nonviable cell count, 
were shown in Tables 2 and 3 and graphical representation 
are shown in Figures 2 and 3.
Effect EEAV on hematological parameter
EEAV at the dose of 100 and 200 mg/kg, the hemoglobin 
content in EAC-bearing mice were increased to 10.6 ± 
0.057 and 11.45 ± 0.057. The hemoglobin content in the 
EAC control mice (9.8 ± 0.02) was significantly decreased 
as compared to normal mice (12.85 ± 0.25). The total WBC 
count was significantly higher in the EAC-treated mice 
when compared to normal mice. Whereas EEAV-treated 
mice significantly reduced the WBC count as compared 
to that of control mice. Significant changes observed on 
differential count when extract-treated mice compared to 
EAC control mice [Table 4] [Figure 4].52   Journal of Young Pharmacists Vol 3 / No 1
Biochemical assay
Biochemical assay indicated that EEAV significantly 
reduced the elevated levels of lipid peroxidation, and 
thereby it may act as an antitumor agent. The level of 
lipid peroxidation, catalase, and protein content were 
summarized in Table 5 and graphical representation is 
shown in Figure 5.
DISCUSSION
This study was carried out to evaluate the antitumor effect 
and antioxidant status of plant extract in EAC-bearing 
mice. The plant extract-treated animals at the doses of 150 
and 250 mg/kg significantly inhibited the tumor volume, 
packed cell volume, tumor cell count, and brought back 
the hematological parameters to more or less normal levels. 
The extract also restored the hepatic lipid peroxidation 
and antioxidant enzymes such as CAT in tumor-bearing 
mice to near normal levels. In short-term toxicity studies, 
the administration of plant extract at the dose of 150 
and 250 mg/kg for 14 days did not exhibit any adverse 
effect. In EAC-bearing mice, a regular rapid increase in 
ascites tumor volume was noted. Ascites fluid is the direct 
nutritional source for tumor cells and a rapid increase in 
ascitic fluid with tumor growth would be a means to meet 
the nutritional requirement of tumor cells.[21] Treatment 
Table 4: Effect of ethanol extract of Adiantum venustum on hematological parameters of EAC-treated mice
Parameter Normal  
GRP 1
EAC control  
GRP 2
150 mg/kg  
GRP 3




Hemoglobin (g) 12.85 ± 0.25 9.8 ± 0.02 10.6 ± 0.057 11.45 ± 0.18* 11.7 ± 0.045*
Total RBC million/mmcu 6.65 ± 0.18 3.8 ± 0.035 4.75 ± 0.032 5.42 ± 0.22* 5.8 ± 0.054
Total WBC million/mmcu 7.8 ± 0.045 20.07 ± 0.068* 11.92 ± 0.042 8.85 ± 0.059 9.12 ± 0.055
Lymphocyte 77.75 ± 0.19 33.37 ± 0.56* 52.7 ± 0.50* 60.72 ± 0.36* 59.12 ± 0.30
Monocyte 1.7 ± 0.035 0.82 ± 0.024 1.15 ± 0.014* 1.2 ± 0.045 1.32 ± 0.024
Granulocyte 29.97 ± 0.46 52.6 ± 0.37* 40.87 ± 0.2 31.72 ± 0.63* 41.65 ± 0.29
Values are mean ± SEM, (n = 8). EAC control group compared to normal group. Experimental group compared to EAC control. P < 0.01, *P < 0.05
Table 5: Effect of different doses of ethanolic extract of Adiantum venustum on different biochemical parameter in 
EAC-bearing mice
Parameter Normal  
GRP 1
EAC control  
GRP 2
150 mg/kg  
GRP 3




Lipid peroxidation n mole MDA/g of tissue 0.92 ± 0.02 1.36 ± 0.09* 1.27 ± 0.04* 1.13 ± 0.02 2.45 ± 0.25
Catalase (units/mg tissues) 2.51 ± 0.72 1.71 ± 0.15* 1.75 ± 0.13 2.34 ± 0.23* 3.56 ± 0.63
Protein content (g/100 mL) 12.66 ± 0.69* 17.25 ± 0.76 16.50 ± 0.70 16.10 ± 0.55 20.24 ± 0.47
Values are mean ± SEM, (n = 8). EAC control group compared to normal group. Experimental group compared to EAC control. P < 0.05, *P < 0.05
Figure 5: Graphical representation of effect of EEAV on different 
biochemical parameters
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Figure 4: Graphical representation of effect of Ethanolic Extract of 
A. venstrun don on haematological parameters
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with plant extract inhibited the tumor volume, tumor 
cell count, and increased the percentage of tryphan blue 
positive stained dead cells in tumor-bearing mice. The 
reliable criteria for judging the value of any anticancer 
drug are the rolongation of the life span of animals.[22] 
The plant extract decreased the ascites fluid volume, viable 
cell count, and increased the percentage of life span. It 
may be concluded that plant extract by decreasing the 
nutritional fluid volume and arresting the tumor growth 
increases the life span of EAC-bearing mice. Usually, in 
cancer chemotherapy the major problems that are being 
encountered are of myelosuppression and anemia.[23,24] The 
anemia encountered in tumor-bearing mice is mainly due to 
reduction in RBC or hemoglobin percentage, and this may 
occur either due to iron deficiency or due to hemolytic or 
myelopathic conditions.[25,26] Treatment with plant extract 
brought back the hemoglobin content, RBC, and WBC 
count more or less to normal levels. This indicates that plant 
extract possesses protective action on the hemopoietic 
system. Lipid peroxidation, an autocatalytic free-radical 
chain propagating reaction, is known to be associated with 
pathological conditions of a cell. Malondialdehyde (MDA), 
the end product of lipid peroxidation, was reported to 
be higher in cancer tissues than in nondiseased organ.[27] 
Excessive production of free radicals resulted in oxidative 
stress, which leads to damage of macromolecules, for 
example lipid peroxidation in vivo.[28] It was also reported 
that the presence of tumors in the human body or in 
experimental animals is known to affect many functions 
of the vital organs, especially in the liver, even when the 
site of the tumor does not interfere directly with organ 
function.[29] Plant extract significantly reduced the elevated 
levels of lipid peroxidation and increased the glutathione 
content in EAC-treated mice. The antitumerogenic effect 
of plant extract may be due to the antioxidant, and the 
free-radical quenching property of the phytoconstituents 
of plant extract. Cells are also equipped with enzymatic 
antioxidant mechanisms that play an important role in the 
elimination of free radicals. SOD, CAT, and glutathione 
peroxides are involved in the clearance of superoxide and 
hydrogen peroxide (H2O2). SOD catalyses the diminution 
of superoxide into H2O2, which has to be eliminated by 
glutathione peroxidase and/or catalase.[30] A small amount 
of catalase in tumor cells was reported.[31] The inhibition 
of SOD and CAT activities as a result of tumor growth 
were also reported.[32] Similar findings were observed in this 
study with EAC-bearing mice. The administration of plant 
extract at different doses significantly increased CAT levels 
in a dose-dependent manner. It was reported that plant-
derived extracts containing antioxidant principles showed 
cytotoxicity toward tumor cells[33] and antitumor activity 
in experimental animals.[34] Antitumor activity of these 
antioxidants is either through induction of apoptosis[35] 
or by inhibition of neovascularization.[36] The implication 
of free radicals in tumors is well documented.[37] The free-
radical hypothesis supported the fact that the antioxidants 
effectively inhibit the tumor, and the observed properties 
may be attributed to the antioxidant and antitumor 
principles present in the extract. This study demonstrates 
that plant extract increased the life span of EAC-tumor-
bearing mice and decreased the lipid peroxidation and 
thereby augmented the endogenous antioxidant enzymes in 
the liver. The above-mentioned parameters are responsible 
for the antitumor and antioxidant activities of A. venstrum 
don. Further investigations are in progress in our laboratory 
to identify the active principles involved in this anticancer 
and antioxidant activity.
CONCLUSION
The EEAV possessed significant anticancer and antioxidant 
activity due to the presence of terpenoids and flavonoids. 
Further investigation on various biological activities of this 
plant with different modes will not only validate the types 
of activities claimed by Ayurvedic, Siddha, and traditional 
practitioners, but also will bring out innovation in the field 
of therapeutics.
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